Erratum to:Membrane fusion reverse micelle platforms as potential oral nanocarriers for efficient internalization of free hydrophilic peptides  

作　　者：Mengting Lin Linjie Wu Yiying Lu Xiaoyan Bao Haiqing Zhong Qi Dai Qiyao Yang Yiyi Xia Xin Tan Yaxin Qin Ruolin Jiang Min Han 

机构地区：[1]Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China [2]Department of Pharmacy,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,China [3]Hangzhou Institute of Innovative Medicine,Zhejiang University,Hangzhou 310058,China [4]The Second Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310058,China

出　　处：《Nano Research》2023年第7期10712-10712,共1页纳米研究（英文版）

摘　　要：Erratum to Nano Research 2023,16(7):9768-9780 https://doi.org/10.1007/s12274-023-5645-7 The complete affiliations of co-author Yiying Lu is Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China and Department of Pharmacy,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,China.

关 键 词：China PHARMACY POTENTIAL 

分 类 号：TB383-5[一般工业技术—材料科学与工程] G23[文化科学]